CN Patent

CN111909157B — Ezh2抑制剂及其用途

Assigned to Nanjing Maisheng Technology Co ltd · Expires 2023-02-03 · 3y expired

What this patent protects

本发明为EZH2抑制剂及其用途，提供一种由式(I)表示的化合物，或其药学上可接受的盐、酯、前药、络合物、溶剂化物、水合物或异构体；以及其用于制备EZH2介导的疾病药物中的用途。

USPTO Abstract

本发明为EZH2抑制剂及其用途，提供一种由式(I)表示的化合物，或其药学上可接受的盐、酯、前药、络合物、溶剂化物、水合物或异构体；以及其用于制备EZH2介导的疾病药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN111909157B
Jurisdiction
CN
Classification
—
Expires
2023-02-03
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Maisheng Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.